Disclosures for "A Disease-specific Transcriptional Biomarker to Functionally Validate Rare Pathogenic Variants in SETX"
-
Ms. Ngo has nothing to disclose.
-
The institution of an immediate family member of Dr. Wong has received research support from NIH.
-
Mr. Huang has nothing to disclose.
-
Dr. Lee has nothing to disclose.
-
Dr. Nelson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PTC Therapeutics. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NSPHARMA . Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for REGENXBIO. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Entrada. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REGENXBIO. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NSPHARMA. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for PTC Therapeutics. Dr. Nelson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Finnegan. The institution of Dr. Nelson has received research support from NIH. The institution of Dr. Nelson has received research support from Department of Defense. The institution of Dr. Nelson has received research support from California Institute of Regenerative Medicine. The institution of Dr. Nelson has received research support from MDA. The institution of Dr. Nelson has received research support from Parent Project Muscular Dystrophy. The institution of Dr. Nelson has received research support from Edgewise.
-
Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromarkers. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. The institution of Dr. Fogel has received research support from US Department of Defense .